Return to site

Cardiac PoC Testing Devices Market 2023: A Valuation of US$ 2.47 Billion Predicted by 2028 | IMARC Group

IMARC Group, a leading market research company, has recently releases report titled “Cardiac PoC Testing Devices Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the cardiac PoC testing devices market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

broken image

How big is the Cardiac PoC Testing Devices Market?

The global cardiac PoC testing devices market size reached US$ 1.75 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 2.47 Billion by 2028, exhibiting a growth rate (CAGR) of 6.10% during 2023-2028.

What is cardiac PoC testing devices?

Cardiac Point of Care (PoC) testing devices are crucial tools in the field of healthcare and cardiology. These devices are designed to provide rapid and accurate diagnostic information about a patient's cardiovascular health at the point of care, typically within clinical settings like hospitals, clinics, or a patient's home. They encompass a range of technologies, including handheld electrocardiography (ECG) devices, blood pressure monitors, cardiac biomarker analyzers, and more. These devices play a pivotal role in the early detection, monitoring, and management of cardiovascular conditions, such as heart disease, arrhythmias, and heart attacks, allowing healthcare professionals to make timely and informed decisions to improve patient outcomes.

What are the growth prospects and trends in the cardiac PoC testing devices industry?

The global cardiac PoC testing devices market is primarily driven by the rise in cardiovascular diseases worldwide. Conditions like coronary artery disease, heart failure, and hypertension are becoming increasingly prevalent due to factors such as sedentary lifestyles, unhealthy diets, and aging populations. As a result, there is a growing need for efficient and accessible diagnostic tools to detect and manage these conditions early, spurring the demand for cardiac PoC testing devices. Besides this, the market is witnessing a surge in technological advancements, which are enhancing the accuracy, speed, and convenience of cardiovascular diagnostics.

For instance, the integration of wireless connectivity and mobile applications allows for real-time data transmission and remote monitoring, improving patient care and reducing healthcare costs, which, in turn, is driving the market growth. Furthermore, the growing emphasis on patient-centered care has encouraged healthcare providers to increasingly adopt cardiac PoC testing devices to enhance patient engagement and experience. These devices empower patients to actively participate in their own healthcare management, as they can monitor their cardiovascular health in the comfort of their homes. This trend aligns with the broader shift towards preventive healthcare and personalized medicine, thereby creating positive growth opportunities in the market. Moreover, access to healthcare services remains a concern in many parts of the world. Cardiac PoC testing devices are playing a pivotal role in addressing this issue by extending healthcare access to underserved and remote regions. These devices enable healthcare providers to reach patients in rural areas and diagnose cardiovascular conditions swiftly, reducing disparities in healthcare delivery.

Who are the key players operating in the industry?

The report covers the major market players including:

  • Abbott Laboratories
  • ACON Laboratories Inc.
  • Alfa Scientific Designs Inc.
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • LifeSign LLC
  • Nano-Ditech Corporation
  • Nexus-Dx Inc.

What is included in market segmentation?

The report has segmented the market into the following categories:

Product Type Insights:

  • Cardiac Markers Test
    • Cardiac Troponin (cTn) Test
    • Myoglobin Test
    • Creatine Kinase MB Isoenzyme (CK-MB) Test
    • Combinational Test Kits
    • Brain Natriuretic Peptide (BNP) Test
  • Analyzers

End User Insights:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Regional Insights:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Ask Analyst for 10% Free Customized Report: https://www.imarcgroup.com/request?type=report&id=7971&flag=C

Key Highlights of the Report:

  • Market Performance (2017-2022)
  • Market Outlook (2023-2028)
  • Market Trends
  • Market Drivers and Success Factors
  • The Impact of COVID-19 on the Global Market
  • Value Chain Analysis
  • Structure of the Global Market
  • Comprehensive mapping of the competitive landscape

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States